| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash | 2,237,223 | |||
| Accounts receivable, net | 284,261 | |||
| Inventory, net | 1,035,680 | |||
| Due from vitamedica transition | 471,380 | |||
| Prepaid expenses and other receivables | 1,480,227 | |||
| Current digital assets at fair value | 212,832,396 | |||
| Purchase price receivable - vitamedica | 2,000,000 | |||
| Total current assets | 220,341,167 | |||
| Property and equipment, net | 1,931,498 | |||
| Intangible assets, net | 143,923 | |||
| Goodwill | 848,854 | |||
| Deferred tax asset | 5,948,858 | |||
| Investment in digital company | 750,000 | |||
| Digital assets at fair value, net of current | 187,993,435 | |||
| Other assets | 200,690 | |||
| Right-of-use asset, net | 1,569,742 | |||
| Total other assets | 199,387,000 | |||
| Total assets | 419,728,167 | |||
| Accounts payable | 2,184,897 | |||
| Accrued compensation | 3,176,969 | |||
| Deferred revenue | 51,347 | |||
| Accrued liabilities | 947,076 | |||
| Accrued interest | 1,545,481 | |||
| Acquisition payable | 260,652 | |||
| Current portion of promissory notes | 560,000 | |||
| Short-term treasury debt | 50,000,000 | |||
| Current portion of cygnet subsidiary notes payable | 5,380,910 | |||
| Current portion of operating lease payable | 521,702 | |||
| Total current liabilities | 64,629,034 | |||
| Operating lease payable, net of current portion | 1,145,439 | |||
| Convertible notes payable | 143,161,862 | |||
| Total long-term liabilities | 144,307,301 | |||
| Preferred stock, 0.00001 par value, 10,000,000 shares authorized, and 150,000 and 150,000 shares issued and outstanding, respectively | 2 | |||
| Common stock, 0.00001 par value, 300,000,000 shares authorized, and 58,893,261 and 38,270,571 shares issued and outstanding, respectively | 589 | |||
| Additional paid in capital | 204,586,941 | |||
| Retain earnings (accumulated deficit) | 6,204,300 | |||
| Total stockholders' equity | 210,791,832 | |||
| Total liabilities and stockholders' equity | 419,728,167 | |||
UPEXI, INC. (UPXI)
UPEXI, INC. (UPXI)